Mangumpit, Perry C.

HRN: 21-50-32  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/07/2022
06/14/2022
IV
500mg
Q8
Acute Infectious Diarrhea
Waiting Final Action 
06/08/2022
CEFTRIAXONE 1G (VIAL)
06/08/2022
06/14/2022
IVT
2 G
Once A Day
Gastrointestinal Infection
Waiting Final Action 
06/15/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/15/2022
06/21/2022
IV
4.5 G
Q8H
Intraabdominal Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: